Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchCARDIO
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, German
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchENDOCRINOLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchNEUROLOGY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Tuesday Mar 18, 2025
Tuesday Mar 18, 2025
touchCONGRESS for touchRESPIRATORY
Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. Benedikt Schoser to discuss how these data may apply in clinical practice.
Overview
- Data reviews with Prof. Mozaffar,
- Expert panel discussions with Prof. Mozaffar, Dr Cohen and Prof. Schoser on the themes below
Clinical themes
- Clinical and real-world data on long-term outcomes in Pompe disease
- Outcomes and impact of treatment switching in Pompe disease
- Latest clinical data on current and emerging therapies in Pompe disease
The internationally renowned Pompe disease expert faculty
- Prof. Tahseen Mozaffar, Irvine, CA, USA
- Dr Jennifer L Cohen, Durham, NC, USA
- Prof. Benedikt Schoser, Munich, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is funded by an independent medical education grant from Amicus Therapeutics.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
Thursday Mar 06, 2025
Thursday Mar 06, 2025
touchMDT for touchONCOLOGY
Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors.
The multidisciplinary team and patient advocate:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Patient Advocate – Mr Tony Collier
Tackle Prostate Cancer, London, UK
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
Thursday Mar 06, 2025
Thursday Mar 06, 2025
touchMDT for touchONCOLOGY
Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen.
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
Pathologist – Prof. Albrecht Stenzinger
University of Heidelberg, Heidelberg, Germany
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
Thursday Mar 06, 2025
Thursday Mar 06, 2025
touchMDT for touchONCOLOGY
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC
Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC).
The multidisciplinary team:
Medical oncologist – Dr Alicia Morgans
Dana-Farber Cancer Institute, Boston, Massachusetts, USA
Nurse practitioner – Dr Grace Cullen
John D. Dingell VA Medical Center, Detroit, Michigan, USA
This touchPODCAST is for HCPs outside of the UK only.
This activity is supported by an independent medical education funding request from AstraZeneca.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website: https://touchoncologyime.org/mdt-parp-inhibitors-in-mcrpc/
Thursday Feb 27, 2025
Thursday Feb 27, 2025
touchEXPERT OPINIONS for touchCARDIO
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts
- Dr Sue Pedersen, University of Calgary, Calgary, Canada
- Prof. Carel le Roux, University College Dublin, Dublin, Ireland
- Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA
This touchPODCAST is for healthcare professionals outside of the USA and UK.
This activity is funded by an independent medical education grant from Novo Nordisk A/S.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchCARDIO.com
Thursday Feb 27, 2025
Thursday Feb 27, 2025
touchEXPERT OPINIONS for touchENDOCRINOLOGY
Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity with or without type 2 diabetes (T2D).
The experts
- Dr Sue Pedersen, University of Calgary, Calgary, Canada
- Prof. Carel le Roux, University College Dublin, Dublin, Ireland
- Dr Donna Ryan, Pennington Biomedical Research Center, Baton Rouge, LA, USA
This touchPODCAST is for healthcare professionals outside of the USA and UK.
This activity is funded by an independent medical education grant from Novo Nordisk A/S.
This activity is jointly provided by USF Health and touchIME.
touchIME is an EBAC® accredited provider.
For further information visit our website:
www.touchENDOCRINOLOGY.com
Friday Feb 21, 2025
Friday Feb 21, 2025
touchEXPERT OPINIONS for touchONCOLOGY
Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of these agents through risk stratification and safety considerations.
The experts
- Prof. Carlos Barrios: Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil
- Prof. Dr. med. Peter Fasching: University Hospital Erlangen and Comprehensive Cancer Center, Erlangen-EMN, Germany
- Dr Sonia Pernas: Catalan Institute of Oncology-Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain
This touchPODCAST is for healthcare professionals outside of the UK and the USA.
This activity is funded by an independent medical education grant from Novartis.
This activity is provided by touchIME.
For further information visit our website:
www.touchONCOLOGY.com